Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Àfrica Pedraza-Gutiérrez"'
Autor:
Montserrat Viñas-Bastart, Míriam Oms-Arias, Àfrica Pedraza-Gutiérrez, Irene Lizano-Díez, Eduardo L. Mariño, Pilar Modamio Charles
Publikováno v:
Pharmaceutical Care España, Vol 24, Iss 3 (2022)
Introduction: The use of the fixed-dose combination of tramadol/dexketoprofen in Spain and in other countries has increased considerably. The authorized therapeutic indication for this medicinal product is the short-term symptomatic treatment of mode
Externí odkaz:
https://doaj.org/article/d0c43f21bbb946f9b85192fe1c638a1c
Autor:
Montserrat Viñas-Bastart, Eduardo L. Mariño, Míriam Oms-Arias, Pilar Modamio, Àfrica Pedraza-Gutiérrez, Irene Lizano-Díez
Background: The increase of consumption of the fixed-dose combination of tramadol/dexketoprofen in Spain and other countries is noteworthy. The authorised therapeutic indication is symptomatic short-term treatment of moderate to severe acute pain in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ef64a695987c369e7c96ce949d563b2
https://doi.org/10.21203/rs.3.rs-359408/v1
https://doi.org/10.21203/rs.3.rs-359408/v1
Autor:
Míriam Oms-Arias, Irene Lizano-Díez, Eduardo L. Mariño, Àfrica Pedraza-Gutiérrez, Montserrat Viñas-Bastart, Pilar Modamio
Publikováno v:
Risk Management and Healthcare Policy
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Montserrat Viñas-Bastart,1 MÃriam Oms-Arias,2 Ãfrica Pedraza-Gutiérrez,2 Irene Lizano-DÃez,1 Eduardo L Mariño,1 Pilar Modamio1 1Clinical Pharmacy and Pharmaceutical Care Unit, Department of Pharmacy and Pharmaceutical Technology, an
Autor:
Pilar Modamio, Montserrat Viñas-Bastart, Eduardo L. Mariño, Míriam Oms-Arias, Irene Lizano-Díez, Àfrica Pedraza-Gutiérrez
Publikováno v:
Pain medicine (Malden, Mass.). 19(8)
Objective The aim of this study was to determine the pattern of use of pregabalin and the appropriateness of treatment, so that interventions could be designed to improve various clinical approaches to the use of pregabalin to include unlicensed indi